Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 455)
Posted On: 07/06/2020 6:00:50 PM
Post# of 36568
Posted By: skipper1072
New BARDA Award: Chembio USA
Product Name: DPP® COVID-19 Ag System
Description:
SARS-CoV-2 point-of-care antigen detection assay, using Chembio’s patented DPP® (lateral flow based) and DPP Micro Reader for diagnosis of COVID-19 from respiratory specimens.


Unique Impact:
The development of an EUA cleared rapid SARS-CoV-2 point-of-care diagnostic, with the ability to rapidly scale production to provide an easy to use test that will increase the United States COVID-19 diagnostic testing capacity.


Base Award Amount: $628,071 (July 5, 2020)

Cost Share: Yes













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site